QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols
QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols Date-30/11/2021 Tetra Bio-Pharma Confirms Meeting with the FDA to Align on the Requirements for Marketing […]

